These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
528 related items for PubMed ID: 31706671
1. ALCL by any other name: the many facets of anaplastic large cell lymphoma. Irshaid L, Xu ML. Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671 [Abstract] [Full Text] [Related]
7. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K, Pileri S, Falini B. Blood; 2000 Dec 01; 96(12):3681-95. PubMed ID: 11090048 [Abstract] [Full Text] [Related]
8. JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK - Anaplastic Large Cell Lymphomas : New Insights into Their Heterogeneity. Wang JC, Zhong LH, Lin WQ, Zhang WF, Xi YF, Liu YP, Zhu Q, Liu W, Zhu WF, Chen YP, Chen G. Am J Surg Pathol; 2023 Jan 01; 47(1):55-64. PubMed ID: 36315833 [Abstract] [Full Text] [Related]
11. ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway. Parkhi M, Bal A, Das A, Kashyap D, Bhardwaj S, Prakash G, Malhotra P. Appl Immunohistochem Mol Morphol; 2021 Oct 01; 29(9):648-656. PubMed ID: 33901030 [Abstract] [Full Text] [Related]
12. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management. Shustov A, Soma L. Cancer Treat Res; 2019 Oct 01; 176():127-144. PubMed ID: 30596216 [Abstract] [Full Text] [Related]
13. Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative. Ganapathi KA, Nicolae A, Egan C, Geng H, Xi L, Pack SD, McFadden JR, Raffeld M, Jaffe ES, Pittaluga S. Br J Haematol; 2024 May 01; 204(5):1862-1871. PubMed ID: 38613165 [Abstract] [Full Text] [Related]
14. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR, Ansell SM, Ketterling RP, Rech KL, Feldman AL. Hum Pathol; 2017 Jun 01; 64():19-27. PubMed ID: 28153507 [Abstract] [Full Text] [Related]
15. Genetics of anaplastic large cell lymphoma. Zeng Y, Feldman AL. Leuk Lymphoma; 2016 Jun 01; 57(1):21-7. PubMed ID: 26104084 [Abstract] [Full Text] [Related]
16. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma. Ravindran A, Feldman AL, Ketterling RP, Dasari S, Rech KL, McPhail ED, Kurtin PJ, Shi M. Am J Surg Pathol; 2021 Apr 01; 45(4):550-557. PubMed ID: 33165091 [Abstract] [Full Text] [Related]
17. The clinicopathological relevance of uniform CD56 expression in anaplastic large cell lymphoma: a retrospective analysis of 18 cases. Yu BH, Zhang Y, Xue T, Shui RH, Lu HF, Zhou XY, Zhu XZ, Li XQ. Diagn Pathol; 2021 Jan 05; 16(1):1. PubMed ID: 33402163 [Abstract] [Full Text] [Related]
20. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG. Leukemia; 2000 Sep 01; 14(9):1533-59. PubMed ID: 10994999 [Abstract] [Full Text] [Related] Page: [Next] [New Search]